NASDAQ$EHTH
eHealth Inc · Q3 2024 earnings
Q3 2024 earnings · · Investor relations
Briefing
eHealth reported revenue and profitability targets, with Medicare application volume growth and AEP preparations completed.
eHealth, Inc. announced its Q3 2024 financial results, achieving revenue and profitability targets while experiencing growth in Medicare application volume. Total revenue decreased by 10% year-over-year to $58.4 million, while Medicare submissions grew by 22%. The company reiterated its full-year 2024 guidance.
- Medicare submissions across core agency and Amplify platforms grew 22% year-over-year.
- Total Medicare approved members increased 6% year-over-year.
- Total revenue decreased 10% year-over-year to $58.4 million.
- GAAP net loss of $42.5 million increased 15% year-over-year.
Headline financials
Revenue & EPS history
eHealth · Revenue · Quarterly
$58.4M
Revenue by segment
eHealth · $64.7M total across 2 segments · Q3 2023
- Medicare$55.5M+23.0%85.8%
- Employer and Individual$9.2M—14.2%
Forward guidance
eHealth reiterates its full year ending December 31, 2024 guidance.
Tailwinds
- Total revenue is expected to be in the range of $470.0 million to $495.0 million.
- GAAP net income (loss) is expected to be in the range of $(36.5) million to $(22.0) million.
- Adjusted EBITDA is expected to be in the range of $7.5 million to $25.0 million.
- Operating cash flow is expected to be in the range of $(10.0) million to $0.0 million.
- Mid-point of 2024 guidance reflects approximately 15% growth in Non-GAAP total revenue excluding net adjustment revenue.
Headwinds
- Actual results may be materially different and are affected by the risk factors and uncertainties.
- The above guidance includes the expected impact of positive net adjustment revenue in the range of $14 to $20 million.
- The guidance is based on information available as of November 6, 2024.
- Assumes no obligation to update these statements.
- Expectations are forward-looking statements.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2024
-1.0%
Avg return
Earnings day
-1.1%
Avg return
5 days after
+0.6%
Avg return
30 days after
45%
29 / 65 earnings
Positive
+25.2%
Q3 2022
Best reaction
-34.3%
Q2 2014
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +1.5% | -7.1% | -12.7% | |
| Q4 2025 | -30.7% | -17.5% | -32.3% | |
| Q3 2025 | -21.8% | -16.2% | -22.9% | |
| Q1 2025 | +23.2% | +19.2% | -8.1% | |
| Q4 2024 | +3.3% | -5.7% | -28.2% | |
| Q3 2024 | +9.2% | +3.5% | +12.2% | |
| Q2 2024 | -12.8% | -7.7% | -18.8% | |
| Q1 2024 | +12.4% | +8.2% | +9.4% | |
| Q4 2023 | -8.2% | -7.1% | -14.6% | |
| Q3 2023 | -8.5% | -11.7% | +2.1% | |
| Q2 2023 | -0.1% | -1.1% | -14.2% | |
| Q1 2023 | +15.1% | +8.2% | +49.1% | |
| Q4 2022 | -8.4% | +2.5% | +5.4% | |
| Q3 2022 | +25.2% | +27.8% | +47.4% | |
| Q2 2022 | -2.7% | +16.8% | -32.2% | |
| Q1 2022 | +22.5% | +31.1% | +31.1% | |
| Q4 2021 | -16.7% | -25.5% | -20.1% | |
| Q3 2021 | -25.8% | -30.7% | -35.2% | |
| Q2 2021 | -5.9% | -9.3% | -28.6% | |
| Q1 2021 | -0.7% | -5.2% | -8.4% | |
| Q4 2020 | +5.9% | +6.6% | +19.4% | |
| Q3 2020 | -6.8% | -8.2% | -8.7% | |
| Q2 2020 | -31.1% | -36.9% | -40.3% | |
| Q1 2020 | -8.1% | -7.1% | +12.4% | |
| Q4 2019 | -0.6% | -13.7% | -22.3% | |
| Q3 2019 | +0.2% | +10.8% | +39.3% | |
| Q2 2019 | +24.8% | +21.5% | +10.5% | |
| Q1 2019 | +3.7% | -2.0% | +4.3% | |
| Q4 2018 | -3.6% | -7.2% | -4.9% | |
| Q3 2018 | +13.2% | +15.2% | +23.0% | |
| Q2 2018 | -3.6% | -1.2% | +24.6% | |
| Q1 2018 | +17.3% | +21.6% | +31.9% | |
| Q4 2017 | -16.2% | -4.1% | -12.2% | |
| Q3 2017 | +7.0% | +15.3% | +3.5% | |
| Q2 2017 | -5.3% | -8.3% | +23.3% | |
| Q1 2017 | +23.2% | +39.6% | +59.9% | |
| Q4 2016 | +8.9% | +6.3% | +2.5% | |
| Q3 2016 | -31.8% | -30.2% | -5.6% | |
| Q2 2016 | -29.4% | -32.2% | -18.6% | |
| Q1 2016 | +23.2% | — | — | |
| Q4 2015 | +0.7% | — | — | |
| Q3 2015 | -4.2% | — | — | |
| Q2 2015 | +21.4% | — | — | |
| Q1 2015 | +13.5% | — | — | |
| Q4 2014 | -3.6% | — | — | |
| Q3 2014 | +15.4% | — | — | |
| Q2 2014 | -34.3% | — | — | |
| Q1 2014 | -12.3% | — | — | |
| Q4 2013 | -8.5% | — | — | |
| Q3 2013 | +9.6% | — | — | |
| Q2 2013 | -1.8% | — | — | |
| Q1 2013 | +7.3% | — | — | |
| Q4 2012 | -22.8% | — | — | |
| Q3 2012 | +9.5% | — | — | |
| Q4 2011 | -1.1% | — | — | |
| Q2 2012 | +9.7% | — | — | |
| Q1 2011 | +1.0% | — | — | |
| Q1 2012 | +0.6% | — | — | |
| Q4 2009 | -2.5% | — | — | |
| Q3 2010 | -3.1% | — | — | |
| Q3 2011 | -3.1% | — | — | |
| Q4 2010 | -7.0% | — | — | |
| Q2 2011 | -7.0% | — | — | |
| Q2 2010 | -7.0% | — | — | |
| Q1 2010 | +2.0% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro